Exosomes are naturally occurring biocompatible, low immunogenic nanovesicles that can deliver genetic material with high specificity to target tissues. In addition, exosomes can be seamlessly ...
This segment also supports customers across various aspects of design, development, and manufacturing, including particle engineering ... exosome-based therapies, as well as viral vector gene ...
Various modified strategies of exosome generation through chemical methods or genetic engineering may overcome these barriers to improve the carrying capacity and specificity for a better therapeutic ...
Developmental biologist Zhi-kun Li of the Chinese Academy of Sciences, first author of the new study, said it represents "a notable accomplishment in mammalian genetic engineering." He said the ...
Humans have appreciated the beauty of flowers for centuries. Yet, flowers aren't just aesthetically pleasing. They also play ...
AI chipmaker Nvidia and research partners have created what they call the largest artificial intelligence system yet for ...
Researchers developed a new gene-editing strategy that dramatically boosts the effectiveness of gene therapies in the liver, a breakthrough that could lead to new treatments for about 700 genetic ...
This expertise positions MaxCyte to support both ex vivo and in vivo cell and gene therapy developers in the process development stage through standardization of the cell engineering workflow.
Brexogen, a biotechnology company specializing in exosome-based therapeutics, has signed a technology transfer and licensing ...
Dec. 10, 2024 — In a single IV injection, a gene therapy targeting cBIN1 can reverse the effects of heart failure and restore heart function in a large animal model. The therapy increases the ...
Evo 2 now includes information from humans, plants, and other eukaryotic species to expand its capabilities in generative functional genomics.
Disease Gene Engineering, Genomic Medicine Center, and leader of The Younger Laboratory, Children's Mercy. "Instead of waiting more than a year for cell models to be generated before experiments ...